Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Dr. Hoenle AG ( (DE:HNL) ) just unveiled an announcement.
Hoenle AG has announced the pre-release of its financial reports for the fiscal year 2024/25, covering the period from October 1, 2024, to September 30, 2025. The reports, including both the year report and the group year report, are scheduled to be published on January 29, 2026, on their website. This announcement is significant as it provides stakeholders with a timeline for when they can expect detailed financial insights, potentially impacting investor decisions and market perceptions.
The most recent analyst rating on (DE:HNL) stock is a Hold with a EUR8.50 price target. To see the full list of analyst forecasts on Dr. Hoenle AG stock, see the DE:HNL Stock Forecast page.
More about Dr. Hoenle AG
Average Trading Volume: 6,086
Technical Sentiment Signal: Strong Sell
Current Market Cap: €51.28M
See more insights into HNL stock on TipRanks’ Stock Analysis page.